James Mcnamara Ii PhD

Dr. James McNamara is an Adjunct Associate Professor of Internal Medicine - Hematology, Oncology, and Blood and Marrow Transplantation at the University of Iowa and an author of twenty-four peer-reviewed scientific articles, including the formative, high-impact publication on Staphylococcus aureus micrococcal nuclease which appeared in Nature Medicine (2014). He is an inventor on three U.S. patents, including the key ‘949 patent, and has two patents pending. James has generated over $2.3 M in dedicated grant funding for the core Nuclease-Activated Probe (NucAP™) technology.

James successfully negotiated the license for his invention from the University of Iowa Research Foundation (UIRF). James founded Nuclease Probe Technologies, NPT, in 2014 based on his patented work with bacterial nucleases and recruited a team of subject matter experts to provide advisory services. NPT is focused on developing rapid diagnostic assays to detect disease-associated nuclease activities. The early and sensitive detection of infectious diseases has been shown to improve patient outcomes and reduce costs to the healthcare system.